Skip to main content
. 2020 Mar 20;99(12):e19276. doi: 10.1097/MD.0000000000019276

Figure 1.

Figure 1

Treatment response of DEB-TACE in ICC patients. (A) Treatment response of DEB-TACE in patients. (B) Treatment response of DEB-TACE in treated nodules. Comparison among groups was determined by Chi-Squared test. P < .05 was considered significant.